Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.
about
The association between Diabetes mellitus and DepressionTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionNational recommendations: Psychosocial management of diabetes in IndiaRisk of diabetes in U.S. military service members in relation to combat deployment and mental healthCardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.Depressive symptoms and risk of type 2 diabetes in a national sample of middle-aged and older adults: the English longitudinal study of aging.Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study.NIDDK international conference report on diabetes and depression: current understanding and future directionsDepression and ambulatory care sensitive hospitalizations among Medicare beneficiaries with chronic physical conditions.State of the science: depression and type 2 diabetes.Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study.Relationship between glycemic control and depression among American Indians in the Strong Heart StudyAnti-depressant medication use and C-reactive protein: results from two population-based studiesBiological effects of add-on eicosapentaenoic acid supplementation in diabetes mellitus and co-morbid depression: a randomized controlled trial.Depression, stress, and weight loss in individuals with metabolic syndrome in SHINE, a DPP translation study.A review of treating depression in diabetes: emerging findings.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Bidirectional association between depression and type 2 diabetes mellitus in womenEffects of pre- and postnatal exposure to chromium picolinate or picolinic acid on neurological development in CD-1 mice.Antidepressant use and diabetes mellitus risk: a meta-analysis.Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS)The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.Diabetes and psychiatric disorders.Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal womenDepressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?Association between major depression and type 2 diabetes in midlife: findings from the Screening Across the Lifespan Twin StudyEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Marginal structural models for the estimation of the risk of Diabetes Mellitus in the presence of elevated depressive symptoms and antidepressant medication use in the Women's Health Initiative observational and clinical trial cohorts.One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study.Depressive symptoms, psychiatric medication use, and risk of type 2 diabetes: results from the Health and Retirement StudyAssociation between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study.Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activityEffect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's DiseaseCommentary: Antidepressants and diabetes risk: why are there discrepant findings from cohort studies based on patient records and those based on serial phenotyping?Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program.Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.Effect of serotonin modulating pharmacotherapies on body mass index and dysglycaemia among children and adolescents: a systematic review and network meta-analysis protocol.
P2860
Q26741886-4196867B-B32D-4531-BCA4-7C41283C5E5CQ26822066-D27AFFCB-178B-4B5C-8EFF-61E94DB038E3Q30352215-5D87E5C4-25D3-453F-A923-5966ACC31E35Q30495650-67917352-BA61-4A11-9AD4-FCA85D1ECE25Q30500360-DA15B330-BDE9-4DE4-B7E5-65AAFADC0844Q33751510-2178DAAE-4EC5-473C-8987-56232C319F99Q33932661-46217926-B08C-4EAF-BE69-3E5A01DF7FECQ33960231-A9543F08-2E97-48BD-AB69-6FFF78AAEDC2Q34066886-89D3210E-7229-43E3-A2E1-5903A992308FQ34098494-3BB74585-D74A-4A9C-8ECB-6CF2D1D300F4Q34351710-C6E80E41-F029-44B2-AF02-DC6E40E4F651Q34351813-8FB4B9D6-7422-4E24-9B9D-24EB7E7F8E59Q34449542-9C695411-FC67-45AE-BDDB-DEA832E3049EQ34459786-7BC3E608-11D6-4BC5-BAD7-547AF3F98671Q34499654-5339DAE8-AEAB-4B28-A058-EEFBF65A862BQ34536292-4393A176-654B-4FBB-B590-FF17A917AB74Q34597335-4F00367E-5C00-4DE4-80D1-FF7CD61C3E5EQ34623350-AC81B866-88D4-4524-9965-B5C5A1B44EF6Q34729968-DE4829E7-5946-4145-8887-5FDEA77E3E52Q34769699-42C23125-E940-404D-AA6D-1D0CF872C853Q34886547-6215AC8B-59DC-469D-AAC2-93B5E60E86E6Q34996871-F73010D4-726C-4083-A7AA-F24A4558DD7DQ35114474-08786C9D-BED8-493E-9073-A8163FA28C22Q35235141-F8DE37F9-B4F9-47B4-A38B-BA82B0C80163Q35352490-95580769-8BCC-4439-8DA8-808CB4DBF608Q35408221-D5D2A177-AD56-4297-8319-0D9F667012A7Q35417546-FDB15293-597B-4434-B87B-BFDFF68E0EF7Q35456399-81904452-9D8D-4D83-A780-B547F07BB02DQ35695980-F5A2B2D3-2F10-4E22-98B9-292424BEAFC9Q35754726-F38E57B5-080E-49F2-BE3B-CA774A1B4817Q35803562-102349CF-98BA-40AE-84A5-D6BC88AB3233Q35819788-0DEEE2C5-C9CF-48CC-AEE7-072697D14F21Q36021649-A98DE018-7595-460D-97B5-C5C27E840FE8Q36048775-B54F8DBE-7FF9-42CB-995A-939B8967E681Q36132836-D8808D74-A32C-44B4-B242-D9D8A4293508Q36194233-E41DCD91-81EC-44F9-A99D-C0212930DA76Q36401071-8C538B43-DF3D-484C-88D3-F6542B689DF3Q36560357-C5DBD507-690E-4CC7-8041-BA5A0851462EQ36674976-C483877A-7EC1-432F-9E4A-76052CEE8F64Q36707440-D218605B-CBC6-495A-820B-816050BE5A4E
P2860
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Elevated depression symptoms, ...... e diabetes prevention program.
@ast
Elevated depression symptoms, ...... e diabetes prevention program.
@en
type
label
Elevated depression symptoms, ...... e diabetes prevention program.
@ast
Elevated depression symptoms, ...... e diabetes prevention program.
@en
prefLabel
Elevated depression symptoms, ...... e diabetes prevention program.
@ast
Elevated depression symptoms, ...... e diabetes prevention program.
@en
P2093
P2860
P50
P356
P1433
P1476
Elevated depression symptoms, ...... e diabetes prevention program.
@en
P2093
David G Marrero
David W Price
Elizabeth L Barrett-Connor
Mark Peyrot
Richard R Rubin
Steven M Haffner
P2860
P304
P356
10.2337/DC07-1827
P407
P577
2007-12-10T00:00:00Z